英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

hydrocyanic    
a. 氰氢的

氰氢的


请选择你想看的字典辞典：
单词字典翻译
hydrocyanic查看　hydrocyanic　在百度字典中的解释百度英翻中〔查看〕
hydrocyanic查看　hydrocyanic　在Google字典中的解释Google英翻中〔查看〕
hydrocyanic查看　hydrocyanic　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Adstiladrin: Uses, Dosage, Side Effects Warnings - Drugs. com
    Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus CalmetteGuérin (BCG)-unresponsive non-muscle invasive bladder cancer Includes Adstiladrin side effects, interactions and indications
  • ADSTILADRIN | FDA
    For the treatment of High-grade, Bacillus Calmette-Guerin (BCG) unresponsive non-muscle invasive bladder cancer
  • ADSTILADRIN® (nadofaragene firadenovec-vncg) | For HCP
    Nadofaragene firadenovec- vncg (ADSTILADRIN) is A recommended treatment option: In the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)* and the AUA SUO Guidelines1 By the International Bladder Cancer Group (IBCG) for high-risk NMIBC after BCG failure for those seeking to avoid radical cystectomy 2
  • ADSTILADRIN® (nadofaragene firadenovec-vncg) | NMIBC Treatment
    STIL EFFECTIVE out to 5 years In a clinical study, ADSTILADRIN was tested in people with high-risk NMIBC whose cancer did not respond to BCG They had checkups over 5 years to measure how well treatment helped them keep their bladder, avoid progressing to MIBC, and remain free of high-grade bladder cancer signs
  • Nadofaragene firadenovec-vncg (urinary bladder route)
    Description Nadofaragene Firadenovec-vncg is used to treat patients with high-risk Bacillus Calmette-Guerin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) with a tumor type called carcinoma in situ (CIS) with or without papillary tumors This medicine is to be used only by or under the direct supervision of a doctor
  • First Bladder Cancer Patient Dosed with Commercially . . .
    First Bladder Cancer Patient Dosed with Commercially Available Intravesical Gene Therapy ADSTILADRIN® (nadofaragene firadenovec-vncg) Urologists treating eligible high-risk bladder cancer patients at participating early experience program clinics in the U S can now prescribe the first and only FDA-approved intravesical gene therapy
  • Adstiladrin (Nadofaragene Firadenovec-Vncg) for bladder . . .
    Adstiladrin is also called nadofaragene firadenovec-vncg Adstiladrin is a gene therapy that uses a non-replicating adenoviral vector (a modified virus that cannot multiply) to deliver a gene to bladder cells This gene makes a protein called interferon alfa-2b, which activates the immune system to fight cancer cells How do I take it?
  • Adstiladrin | European Medicines Agency (EMA)
    Nadofaragene firadenovec is a non-replicating, recombinant type 5 adenovirus vector-based gene therapy containing the human IFNα2b transgene Its intravesical administration results in the entry of viral particles into the tumour cells and the urothelium of the bladder, leading to the expression of the IFNα2b protein in such cells, which in
  • Nadofaragene Firadenovec-vncg - NCI - National Cancer Institute
    This page contains brief information about nadofaragene firadenovec-vncg and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials
  • Intravesical nadofaragene firadenovec gene therapy for BCG . . .
    Intravesical nadofaragene firadenovec was efficacious, with a favourable benefit:risk ratio, in patients with BCG-unresponsive non-muscle-invasive bladder cancer This represents a novel treatment option in a therapeutically challenging disease state





中文字典-英文字典  2005-2009